A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Cancer and Other Solid Tumors

Clinical trial NCT06500052 · RECRUITING

Trial details

NCT number: NCT06500052
Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Esophageal Cancer Gastric Cancer Pancreatic Cancer Colorectal Cancer Solid Tumor

Start date: 2024-07-24
Primary completion: 2026-08-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.